Literature DB >> 8863037

Giardiasis.

M J Farthing1.   

Abstract

Despite rapid progress in understanding the biology of Giardia, several questions remain unanswered. First, there is no adequate explanation for the diverse clinical spectrum of giardiasis. Second, the mechanisms by which Giardia produces diarrhea and malabsorption are poorly understood, although some progress has been made. Finally, despite extensive studies in animal models and human infections, the key immunologic determinants for clearance of acute infection and development of protective immunity remain ill defined. This article discusses the epidemiology, pathology, diagnosis, treatment, and prevention of giardiasis.

Entities:  

Mesh:

Year:  1996        PMID: 8863037     DOI: 10.1016/s0889-8553(05)70260-0

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  50 in total

Review 1.  Tropical malabsorption.

Authors:  B S Ramakrishna; S Venkataraman; A Mukhopadhya
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 2.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Chronic diarrhoea.

Authors:  R Spiller
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

4.  Adaptive immune response in symptomatic and asymptomatic enteric protozoal infection: evidence for a determining role of parasite genetic heterogeneity in host immunity to human giardiasis.

Authors:  Zahra Babaei; Najmeh Malihi; Naser Zia-Ali; Iraj Sharifi; Mohammad A Mohammadi; Martin F Kagnoff; Lars Eckmann; Steven M Singer; Shahram Solaymani-Mohammadi
Journal:  Microbes Infect       Date:  2016-07-08       Impact factor: 2.700

5.  Methionyl-tRNA synthetase inhibitor has potent in vivo activity in a novel Giardia lamblia luciferase murine infection model.

Authors:  Samantha A Michaels; Han-Wei Shih; Bailin Zhang; Edelmar D Navaluna; Zhongsheng Zhang; Ranae M Ranade; J Robert Gillespie; Ethan A Merritt; Erkang Fan; Frederick S Buckner; Alexander R Paredez; Kayode K Ojo
Journal:  J Antimicrob Chemother       Date:  2020-05-01       Impact factor: 5.790

6.  Giardia muris infection in mice is associated with a protective interleukin 17A response and induction of peroxisome proliferator-activated receptor alpha.

Authors:  Leentje Dreesen; Karolien De Bosscher; Grietje Grit; Bart Staels; Erik Lubberts; Eric Bauge; Peter Geldhof
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

7.  Changes in beta-giardin sequence of Giardia intestinalis sensitive and resistant to albendazole strains.

Authors:  Enedina Jiménez-Cardoso; Leticia Eligio-García; Adrián Cortés-Campos; Andrés Flores-Luna; Pedro Valencia-Mayoral; Irma Lozada-Chávez
Journal:  Parasitol Res       Date:  2009-02-13       Impact factor: 2.289

8.  Crystal structure of a macrophage migration inhibitory factor from Giardia lamblia.

Authors:  Garry W Buchko; Jan Abendroth; Howard Robinson; Yanfeng Zhang; Stephen N Hewitt; Thomas E Edwards; Wesley C Van Voorhis; Peter J Myler
Journal:  J Struct Funct Genomics       Date:  2013-05-25

9.  Prevalence of recurring symptoms after infection with Giardia lamblia in a non-endemic area.

Authors:  Knut-Arne Wensaas; Nina Langeland; Guri Rortveit
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

10.  Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after.

Authors:  Kristine Mørch; Kurt Hanevik; Guri Rortveit; Knut-Arne Wensaas; Geir Egil Eide; Trygve Hausken; Nina Langeland
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.